iron complexes
Recently Published Documents


TOTAL DOCUMENTS

2232
(FIVE YEARS 226)

H-INDEX

81
(FIVE YEARS 10)

Author(s):  
Kazimer L. Skubi ◽  
Reagan X. Hooper ◽  
Brandon Q. Mercado ◽  
Melissa M. Bollmeyer ◽  
Samantha N. MacMillan ◽  
...  

Author(s):  
Pamela V. S. Nylund ◽  
Baptiste Monney ◽  
Christoph Weder ◽  
Martin Albrecht

Poly(lactic acid), PLA, which holds great promises as a biodegradable substitute of fossil resource-derived polyolefins, is industrially produced by the ring-opening polymerization of lactide using a potentially harmful tin catalyst....


2021 ◽  
Vol 22 (24) ◽  
pp. 13649
Author(s):  
Olga V. Kosmachevskaya ◽  
Elvira I. Nasybullina ◽  
Konstantin B. Shumaev ◽  
Natalia N. Novikova ◽  
Alexey F. Topunov

Dinitrosyl iron complexes (DNICs) are a physiological form of nitric oxide (•NO) in an organism. They are able not only to deposit and transport •NO, but are also to act as antioxidant and antiradical agents. However, the mechanics of hemoglobin-bound DNICs (Hb-DNICs) protecting Hb against peroxynitrite-caused, mediated oxidative modification have not yet been scrutinized. Through EPR spectroscopy we show that Hb-DNICs are destroyed under the peroxynitrite action in a dose-dependent manner. At the same time, DNICs inhibit the oxidation of tryptophan and tyrosine residues and formation of carbonyl derivatives. They also prevent the formation of covalent crosslinks between Hb subunits and degradation of a heme group. These effects can arise from the oxoferryl heme form being reduced, and they can be connected with the ability of DNICs to directly intercept peroxynitrite and free radicals, which emerge due to its homolysis. These data show that DNICs may ensure protection from myocardial ischemia.


Author(s):  
Umberto Piarulli ◽  
Giovanni Maria Fusi ◽  
Silvia Gazzola

Sign in / Sign up

Export Citation Format

Share Document